SEC Filing Alert NT 10-K: Notice under Rule 12b2
Post# of 148278
NT 10-K: Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
CytoDyn, Inc. (the “Company”) is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the fiscal year ended May 31, 2022 (the “Form 10-K”) because it requires additional time to complete the external audit of those statements included in the Form 10-K. The Company has experienced unexpected delays in completing the external audit due to the time required to evaluate alternative accounting treatment of non-cash expense related to settlement of convertible debt with equity instruments. The Form 10-K is expected to be filed not later than August 15, 2022 .
https://ir.stockpr.com/cytodyn/sec-filings-em...xnt10k.htm